BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 32645691)

  • 1. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
    Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
    Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer.
    Tang X; Sun G; He Q; Wang C; Shi J; Gao L; Ye J; Liang Y; Qu H
    Cell Death Dis; 2020 Aug; 11(8):625. PubMed ID: 32796815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling.
    Luo GC; Chen L; Fang J; Yan ZJ
    Bioengineered; 2021 Dec; 12(2):11089-11107. PubMed ID: 34852706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H
    Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
    Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
    Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA nuclear receptor interacting protein 1 promoted biliary tract cancer epithelial-mesenchymal transition and stemness by regulating the miR-515-5p/AKT2 axis and PI3K/AKT/mTOR signaling pathway.
    Gao X; Yu S; Liu S; Zhang S; Sha X; Sun D; Jiang X
    Environ Toxicol; 2023 Nov; 38(11):2632-2644. PubMed ID: 37466171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircSMARCA5 Facilitates the Progression of Prostate Cancer Through miR-432/PDCD10 Axis.
    Dong C; Fan B; Ren Z; Liu B; Wang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):70-83. PubMed ID: 32407167
    [No Abstract]   [Full Text] [Related]  

  • 11. Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer.
    Gujrati H; Ha S; Waseem M; Wang BD
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.
    Zhang X; Wang S; Wang H; Cao J; Huang X; Chen Z; Xu P; Sun G; Xu J; Lv J; Xu Z
    Mol Cancer; 2019 Feb; 18(1):20. PubMed ID: 30717751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
    Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
    Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-449c-5p availability is antagonized by circ-NOTCH1 for MYC-induced NOTCH1 upregulation as well as tumor metastasis and stemness in gastric cancer.
    Zhao X; Zhong Q; Cheng X; Wang S; Wu R; Leng X; Shao L
    J Cell Biochem; 2020 Oct; 121(10):4052-4063. PubMed ID: 31943342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circMBOAT2 serves as the sponge of miR-433-3p to promote the progression of bladder cancer.
    Yu K; Liu M; Huang Y; Yu Q; Ma D; Dai G; Chen Y
    Pathol Res Pract; 2021 Nov; 227():153613. PubMed ID: 34563754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA Myosin Light Chain Kinase (MYLK) Promotes Prostate Cancer Progression through Modulating Mir-29a Expression.
    Dai Y; Li D; Chen X; Tan X; Gu J; Chen M; Zhang X
    Med Sci Monit; 2018 May; 24():3462-3471. PubMed ID: 29798970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling.
    Liu DC; Song LL; Li XZ; Liang Q; Zhang ZG; Han CH
    Clin Transl Oncol; 2021 Dec; 23(12):2497-2506. PubMed ID: 34142340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a/BRD4 axis.
    Fu B; Liu W; Zhu C; Li P; Wang L; Pan L; Li K; Cai P; Meng M; Wang Y; Zhang A; Tang W; An M
    Int J Biol Sci; 2021; 17(12):3104-3117. PubMed ID: 34421353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.